INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 23 filers reported holding INHIBIKASE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $46,900 | -44.8% | 93,800 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $85,000 | +21.4% | 93,800 | 0.0% | 0.01% | +20.0% |
| Q2 2022 | $70,000 | -49.6% | 93,800 | 0.0% | 0.01% | -28.6% |
| Q1 2022 | $139,000 | +0.7% | 93,800 | 0.0% | 0.01% | -12.5% |
| Q4 2021 | $138,000 | -22.5% | 93,800 | 0.0% | 0.01% | -20.0% |
| Q3 2021 | $178,000 | -32.3% | 93,800 | 0.0% | 0.01% | -41.2% |
| Q2 2021 | $263,000 | +132.7% | 93,800 | +398.9% | 0.02% | +112.5% |
| Q1 2021 | $113,000 | -13.1% | 18,800 | 0.0% | 0.01% | -27.3% |
| Q4 2020 | $130,000 | – | 18,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 1,010,000 | $1,919,000 | 1.00% |
| Murchinson Ltd. | 320,947 | $610,000 | 0.30% |
| SABBY MANAGEMENT, LLC | 425,014 | $808,000 | 0.11% |
| Kepos Capital LP | 700,000 | $1,330,000 | 0.09% |
| Antara Capital LP | 303,000 | $576,000 | 0.04% |
| ZEKE CAPITAL ADVISORS, LLC | 93,800 | $178,000 | 0.01% |
| Warberg Asset Management LLC | 26,000 | $49,000 | 0.01% |
| Shay Capital LLC | 20,000 | $38,000 | 0.01% |
| WELLS FARGO & COMPANY/MN | 122 | $0 | 0.00% |
| NORTHERN TRUST CORP | 15,714 | $30,000 | 0.00% |